Literature DB >> 36227452

Clinical research diagnostic criteria for bipolar illness (CRDC-BP): rationale and validity.

S Nassir Ghaemi1,2, Jules Angst3, Paul A Vohringer4,5, Eric A Youngstrom6, James Phelps7, Philip B Mitchell8, Roger S McIntyre9, Michael Bauer10, Eduard Vieta11, Samuel Gershon12.   

Abstract

BACKGROUND: In the 1970 s, scientific research on psychiatric nosology was summarized in Research Diagnostic Criteria (RDC), based solely on empirical data, an important source for the third revision of the official nomenclature of the American Psychiatric Association in 1980, the Diagnostic and Statistical Manual, Third Edition (DSM-III). The intervening years, especially with the fourth edition in 1994, saw a shift to a more overtly "pragmatic" approach to diagnostic definitions, which were constructed for many purposes, with research evidence being only one consideration. The latest editions have been criticized as failing to be useful for research. Biological and clinical research rests on the validity of diagnostic definitions that are supported by firm empirical foundations, but critics note that DSM criteria have failed to prioritize research data in favor of "pragmatic" considerations.
RESULTS: Based on prior work of the International Society for Bipolar Diagnostic Guidelines Task Force, we propose here Clinical Research Diagnostic Criteria for Bipolar Illness (CRDC-BP) for use in research studies, with the hope that these criteria may lead to further refinement of diagnostic definitions for other major mental illnesses in the future. New proposals are provided for mixed states, mood temperaments, and duration of episodes.
CONCLUSIONS: A new CRDC could provide guidance toward an empirically-based, scientific psychiatric nosology, and provide an alternative clinical diagnostic approach to the DSM system.
© 2022. The Author(s).

Entities:  

Keywords:  Bipolar disorder; CRDC; Classification; DSM; Diagnosis; Nosology; RDC

Year:  2022        PMID: 36227452     DOI: 10.1186/s40345-022-00267-3

Source DB:  PubMed          Journal:  Int J Bipolar Disord        ISSN: 2194-7511


  118 in total

Review 1.  The bipolar spectrum--the shaping of a new paradigm in psychiatry.

Authors:  Hagop S Akiskal
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

2.  TEMPS-I: delineating the most discriminant traits of the cyclothymic, depressive, hyperthymic and irritable temperaments in a nonpatient population.

Authors:  H S Akiskal; G F Placidi; I Maremmani; S Signoretta; A Liguori; R Gervasi; G Mallya; V R Puzantian
Journal:  J Affect Disord       Date:  1998-10       Impact factor: 4.839

3.  Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes.

Authors:  Hagop S Akiskal; Kareen K Akiskal; Sylvie Lancrenon; Elie G Hantouche; Jean-Philippe Fraud; Charles Gury; Jean-Francois Allilaire
Journal:  J Affect Disord       Date:  2006-07-07       Impact factor: 4.839

4.  Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group.

Authors:  H S Akiskal; A M Djenderedjian; R H Rosenthal; M K Khani
Journal:  Am J Psychiatry       Date:  1977-11       Impact factor: 18.112

Review 5.  The evolving bipolar spectrum. Prototypes I, II, III, and IV.

Authors:  H S Akiskal; O Pinto
Journal:  Psychiatr Clin North Am       Date:  1999-09

6.  The bipolar spectrum.

Authors:  Jules Angst
Journal:  Br J Psychiatry       Date:  2007-03       Impact factor: 9.319

Review 7.  The mood spectrum: improving the diagnosis of bipolar disorder.

Authors:  Jules Angst; Giovanni Cassano
Journal:  Bipolar Disord       Date:  2005       Impact factor: 6.744

8.  The emerging epidemiology of hypomania and bipolar II disorder.

Authors:  J Angst
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

Review 9.  The emergence of the bipolar spectrum: validation along clinical-epidemiologic and familial-genetic lines.

Authors:  Hagop S Akiskal
Journal:  Psychopharmacol Bull       Date:  2007

10.  Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II).

Authors:  Hagop S Akiskal; Elie-Georges Hantouche; Jean-François Allilaire; Daniel Sechter; Marc L Bourgeois; Jean-Michel Azorin; Liliane Chatenêt-Duchêne; Sylvie Lancrenon
Journal:  J Affect Disord       Date:  2003-01       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.